Lowe's Q2 adjusted EPS beats, sales miss estimates
Lowe's Companies reports Q2 adjusted EPS of $4.40, above the $4.22 estimate, while sales of $25.956 billion miss the $26.155 billion estimate.
TNON: 110% | Tenon Medical shares are trading higher after the company received a notice of allowance for a U.S.
Patent Titled "Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints" LZB: -18% | La-Z-Boy shares are trading lower after the company reported worse-than-expected Q1 financial results and issued Q2 sales guidance below estimates.
LOW: -3% | Lowe's Companies Q2 Adj.
EPS $4.40 Beats $4.22 Estimate, Sales $25.956B Miss $26.155B Estimate